Clinical trial
Association Between Systemic Exposure of Atorvastatin and Metabolites and…
NCT00120055 · University of Oslo School of Pharmacy, Other · Completed
Key facts
| NCT number | NCT00120055 |
|---|---|
| Title | Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity |
| Lead sponsor | University of Oslo School of Pharmacy, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myopathy |
| Intervention type | Drug |
| Interventions | Atorvastatin (Lipitor) |
| Start date | Feb 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Jul 14, 2005 |
| Last update posted | Dec 3, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: